EU health ministers have set out the Council’s position on a regulation to modernise and simplify the structure of the fees payable to the European Medicines Agency (EMA) to better reflect the ...

European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.

This press release was updated on 11 October 2023 to include the text of the provisional agreement. The presidency of the Council and European Parliament negotiators reached a provisional agreement on ...

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype ...

Alnylam is executing on its “ Alnylam P5x25 ” strategy to deliver transformative medicines in both rare and common diseases benefiting patients around the world through sustainable innovation ...

The European Medicines Agency (EMA) filing is supported by the pivotal ReSTORE Phase III clinical trial results, where rezafungin demonstrated non-inferiority to the current standard of care ...